Table 1

Regulators of mammary morphogenesis and their agonists, antagonists, downstream targets and realm of influence

RegulatorAgonistsAntagonistsTargetsEffects
GH-R (st)GH (pit)IGF-1 (st)General
IGF-1R (ep)IGF-1 (st)IGFBPs (st)UnknownGeneral
ER-α (st/ep)E1/E2 (ov)Amphiregulin et al.General
PR-B (st?)ER, P (ov)Wnt4, RANKLTertiary branching
EGFR (st)Amphiregulin (ep)Sprouty?MMPs, FGFs et al.General
Amphiregulin (ep)ER, ADAM17 (ep)HSPGsEGFR (st)General
ADAM17 (ep)PPCs et al.TIMP3 (ep)Amphiregulin (ep)General
MMP-14 (st)EGFR, PPCs et al.TIMPs 2–4MMP-2, Coll IGeneral
MMP-2 (st?)TGF-β, ER, MMP-14TIMPs 1–4Coll I et al.?Elongation
MMP-3 (st)Epimorphin et al.TGF-β, TIMPsUnknownSecondary branching
FGFR2 (ep)FGFs (st)Sprouty2 (ep)UnknownTEBs
ErbB2 (ep)UnknownUnknownUnknownTEBs
Epimorphin (st/me)MetalloenzymesUnknownC/EPBβ, MMPsBranching
TGF-β1 (ep)ER, MMPs, plasminLAPTGF-βRI/II, MMPsSpacing
CSF-1R (mφ)CSF-1 (ep)Mφ recruitmentTEBs
CCR3 (eos)EotaxinEos recruitmentBranching
Integrin α2β1 (ep)Laminins, collagensTEBs, ducts
DDR1 (ep)CollagensTEBs, ducts

ADAM, a disintegrin and metalloproteinase; CCR, CC chemokine receptor; Coll, collagen; CSF, colony-stimulating factor; DDR, discoidin domain receptor; EGFR, epidermal growth factor receptor; eos, eosinophil; ep, epithelial; E1/E2, estrone/estradiol; ER, estrogen receptor; FGF, fibroblast growth factor; FGFR, FGF receptor; GH, growth hormone; GH-R, growth hormone receptor; HSPG, heparan sulfate proteoglycan; IGF-1, insulin-like growth factor-1; IGF-1R, IGF-1 receptor; IGFBPs, IGF-binding proteins; LAP, latency-associated peptide; me, myoepithelial; MMP, matrix metalloproteinase; mφ, macrophage; ov, ovarian; pit, pituitary; PPC, proprotein convertase; P, progesterone; PR, progesterone receptor; RANKL, receptor activator of nuclear factor κB (RANK) ligand; st, stromal; TEB, terminal end bud; TGF, transforming growth factor; TIMP, tissue inhibitor of metalloproteinases. Required sources are provided in parentheses.